Almirall and Evotec to collaborate on multiple severe skin disease targets
A new dermatological alliance between Spanish skin health firm Almirall and German-listed Evotec aims to discover new drugs for the treatment of skin diseases including cancers and eczema.
by andreas lønstrup, translated by daniel pedersen
A new dermatological multi-target alliance was established on Thursday, as Almirall and Evotec join forces to discover new treatments for a variety of skin diseases, Almirall has announced in a press release.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
.jpg)
.jpg&w=384&q=75)
